Bullboard - Stock Discussion Forum Liminal BioSciences Inc. LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed... see more

Add To Watchlist

NDAQ:LMNL - Post Discussion

Liminal BioSciences Inc. > $5 million bucks for Ryplazim

View:

Post by DryBones on Jun 20, 2021 2:51am

$5 million bucks for Ryplazim

According to the article Kendron has the right to purchase the balance of the plasma collection and the balance of Ryplazim for $5 million. It sure aint worth much is it.

245

Comment

Comment by GoldenJJ on Jun 20, 2021 7:14pm

$5 millions + mildstone payments. It says the milestone payment will be increased if ryplazim is approved by FDA https://app.quotemedia.com/data/downloadFiling?webmasterId=101442&ref=115890350&type=HTML&symbol=LMNL&companyName=Liminal+BioSciences+Inc.&formType=6-K&formDescription=Report+of+foreign+private+issuer+pursuant+to+Rule+13a-16+or+15d-16+under+the+Securities ...more

Comment

Liminal BioSciences Inc.